Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN1A | P35498 | 2/20 | 1.00 |
| ▸ | SCN2A | Q99250 | 2/20 | 1.00 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.53 |
| ▸ | SMPD1 | P17405 | 6/20 | 0.48 |
| ▸ | ABCB1 | P08183 | 6/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HCN4 | Q9Y3Q4 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | ABCC1 | P33527 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tiapamil SCHEMBL635113 | 0.99 | SCN1A (0.98) | SCN1ASCN2ASCN3ACYP3A4CYP1A2 | |
| Bromide SCHEMBL11615923 | 0.95 | SCN1A (0.90) | SCN1ASCN2ASCN3ACYP3A4CYP1A2 | |
| SCHEMBL25861795 | 0.94 | SCN1A (0.89) | SCN1ASCN2ASCN3ACYP3A4CYP1A2 | |
| Hydrochloric Acid SCHEMBL11607284 | 0.93 | SCN1A (0.87) | SCN1ASCN2ASCN3ACYP3A4CYP1A2 | |
| SCHEMBL11614948 | 0.93 | SCN1A (0.86) | SCN1ASCN2ASCN3ACYP3A4CYP1A2 | |
| Hydrochloric Acid SCHEMBL11613134 | 0.92 | SCN1A (0.85) | SCN1ASCN2ASCN3ACYP3A4CYP1A2 | |
| Oxalic Acid SCHEMBL11610568 | 0.92 | SCN1A (0.85) | SCN1ASCN2ASCN3ACYP3A4CYP1A2 | |
| Hydrochloric Acid SCHEMBL11613226 | 0.92 | SCN1A (0.85) | SCN1ASCN2ASCN3ACYP3A4CYP1A2 | |
| Hydrochloric Acid SCHEMBL11726187 | 0.92 | SCN1A (0.85) | SCN1ASCN2ASCN3ACYP3A4CYP1A2 | |
| Hydrochloric Acid SCHEMBL11612658 | 0.92 | SCN1A (0.84) | SCN1ASCN2ASCN3ACYP3A4CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3091 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124180-A1 | METHOD OF TREATING AFFECTIVE DISORDERS AND PERSONALITY DISORDERS | HB BIOTECH, INC. (US) | 2026-05-07 | — | — | US | claimed |
| EP-4724060-A1 | FORMULATIONS AND METHODS FOR TREATING NEUROPSYCHIATRIC DISORDERS | HB Biotech, Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| US-12539291-B2 | Method of treating affective disorders and personality disorders | HB BIOTECH, INC. (US) | 2026-02-03 | — | — | US | claimed |
| US-20260028594-A1 | CELL PATCH CRYOPRESERVATION SOLUTION AND METHOD OF CRYOPRESERVING A CELL PATCH | BOE REGENERATIVE MEDICINE TECH CO LTD (CN) | 2026-01-29 | — | — | US | claimed |
| US-20250152591-A1 | TREATMENT OF HEMATOLOGICAL MALIGNANCIES WITH MENIN INHIBITORS AND P-GLYCOPROTEIN INHIBITORS | KURA ONCOLOGY INC (US) | 2025-05-15 | — | — | US | claimed |
| CN-119173139-A | Cell patch frozen stock solution and cell patch frozen stock method | 京东方科技集团股份有限公司 | 2024-12-20 | — | — | CN | claimed |
| WO-2024254389-A1 | FORMULATIONS AND METHODS FOR TREATING NEUROPSYCHIATRIC DISORDERS | HB BIOTECH, INC. (US) | 2024-12-12 | — | — | WO | claimed |
| EP-4472637-A1 | TREATMENT OF HEMATOLOGICAL MALIGNANCIES WITH MENIN INHIBITORS AND P-GLYCOPROTEIN INHIBITORS | Kura Oncology, Inc. (US) | 2024-12-11 | — | — | EP | claimed |
| US-12128031-B2 | Method of improving psychosocial health | HB BIOTECH, INC. (US) | 2024-10-29 | — | — | US | claimed |
| WO-2024216594-A1 | CELL SHEET CRYOPRESERVATION SOLUTION AND METHOD FOR CRYOPRESERVING CELL SHEET | 京东方科技集团股份有限公司 | 2024-10-24 | — | — | WO | claimed |
| US-4808413-A | MIXING DRUG, ACID, BINDER, EXTRUSION AND SPHERONIZATION | E. R. SQUIBB & SONS, INC. (US) | 1989-02-28 | — | — | US | claimed |
| US-4783337-A | Osmotic system comprising plurality of members for dispensing drug | ALZA CORPORATION (US) | 1988-11-08 | — | — | US | claimed |
| EP-0288732-A2 | New pharmaceutical compositions in the form of beadlets and method | E.R. Squibb & Sons, Inc. (US) | 1988-11-02 | — | — | EP | claimed |
| US-4782043-A | HYPOTENSIVES | MERCK & CO., INC. (US) | 1988-11-01 | — | — | US | claimed |
| EP-0209897-A2 | Peptide enzyme inhibitors | MERCK & CO. INC. (US) | 1987-01-28 | — | — | EP | claimed |
| US-4584294-A | Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents | MERCK & CO., INC. (US) | 1986-04-22 | — | — | US | claimed |
| EP-0166353-A2 | Benzofused lactams useful as antihypertensive agents and as cholecystokinin antagonists | MERCK & CO. INC. (US) | 1986-01-02 | — | — | EP | claimed |
| EP-0163237-A2 | Di- and tri-peptidal renin inhibitors | MERCK & CO. INC. (US) | 1985-12-04 | — | — | EP | claimed |
| EP-0129189-A2 | Renin inhibitors containing a C-terminal amide cycle and compositions and combinations containing the same | MERCK & CO. INC. (US) | 1984-12-27 | — | — | EP | claimed |
| US-4003914-A | DITHIANE AND DISULFONE CORONARY DILATING AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1977-01-18 | — | — | US | claimed |